ALDX

Aldeyra Therapeutics (ALDX)

About Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Details

Daily high

$2.15

Daily low

$1.95

Price at open

52 Week High

$6.18

52 Week Low

$1.07

Market cap

123.7M

Dividend yield

0.00%

Volume

2,556

Avg. volume

1.2M

P/E ratio

-4.50

Aldeyra Therapeutics News